A genetic polymorphism in transforming growth factor beta receptor 2 is associated with serum osteopontin
Biros, E., Clancy, P., Norman, P.E., and Golledge, J. (2009) A genetic polymorphism in transforming growth factor beta receptor 2 is associated with serum osteopontin. International Journal of Immunogenetics, 36 (4). pp. 241-244.
![[img]](https://researchonline.jcu.edu.au/style/images/fileicons/application_pdf.png) |
PDF (Published Version)
Restricted to Repository staff only |
Abstract
Osteopontin (OPN) is a secreted glycoprotein demonstrated to play an important role in inflammation. Transforming growth factor beta and a related signalling pathway have been implicated in control of OPN secretion. We examined the relationship between transforming growth factor beta receptor-1 and -2 (TGFBR1 and 2) single nucleotide polymorphisms (SNP) and serum OPN in 296 men from the Health in Men Study. Serum concentrations of OPN and 58 SNPs for TGFBR1 and 2 were assessed. One SNP in TGFBR2 was associated with serum OPN (TGFBR2 g.20690C > T, SNP ID rs4522809, P = 0.0007) after adjusting for multiple testing. This study suggests that polymorphism in TGFBR2 are associated with altered secretion of OPN, supporting a role for transforming growth factor beta in OPN production.
| Item ID: | 10667 |
|---|---|
| Item Type: | Article (Research - C1) |
| ISSN: | 1744-313X |
| Date Deposited: | 20 Apr 2010 22:19 |
| FoR Codes: | 11 MEDICAL AND HEALTH SCIENCES > 1102 Cardiovascular Medicine and Haematology > 110201 Cardiology (incl Cardiovascular Diseases) @ 100% |
| SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920103 Cardiovascular System and Diseases @ 40% 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920108 Immune System and Allergy @ 60% |
| Downloads: |
Total: 2 |
| More Statistics |
Actions (Repository Staff Only)
 |
Item Control Page |